---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-026651"
form_type: "8-K"
ticker: "RXST"
cik: "0001111485"
company_name: "RxSight, Inc."
filed_at: "2025-02-25T23:59:59+00:00"
generated_at: "2026-05-26T04:23:39.909439+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# RxSight Q4 revenue $40.2M (+41% YoY), LAL volume +61%; reaffirms FY2025 guidance

## Summary
- Q4 revenue $40.2M (+41% YoY); full-year revenue $139.9M (+57% YoY).
- Q4 net loss $(5.9)M vs $(9.2)M; adjusted net earnings $1.3M ($0.03/share) vs adjusted loss $(4.8M).
- LAL procedure volume 29,069 units (+61% YoY); LDD installed base 971 (+46% YoY).
- FY2025 guidance: revenue $185-197M (32-41% growth), gross margin 71-73%, operating expenses $165-170M.
- Cash and investments $237.2M; no debt mentioned.

## SEC filing metadata
- accession: 0000950170-25-026651
- form_type: 8-K
- ticker: RXST
- cik: 0001111485
- company_name: RxSight, Inc.
- filed_at: 2025-02-25T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1111485/000095017025026651/0000950170-25-026651-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1111485/000095017025026651/rxst-20250225.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-026651
- JSON: https://secwatch.observer/filing/0000950170-25-026651.json
- Plain text: https://secwatch.observer/filing/0000950170-25-026651.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.